Adalimumab Vials and Lanreotide
Determining the interaction of Adalimumab Vials and Lanreotide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: adalimumab
Brand name: Humira, Humira Pen, Humira Pen Crohns/UlcerColit/HidraSuppur, Humira Pen Psoriasis/Uveitis Starter Package, Humira Pediatric, Humira Pediatric Crohn's Disease Starter Pack, Humira Pre-Filled Syringe, Humira Pen Psoriasis/Uveitis/Adol HidraSuppur Starter Pack, Humira Pen Crohns/Ulcer Colitis/Hidradenitis Suppurati StrPk
Synonyms: Adalimumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Adalimumab Vials-Lanreotide Acetate
- Adalimumab Vials-Lanreotide Subcutaneous
- Adalimumab Vials-Lansoprazole
- Adalimumab Vials-Lansoprazole Delayed-Release Capsules
- Adalimumab Vials-Lansoprazole Orally Disintegrating Tablets
- Adalimumab Vials-Lansoprazole, Amoxicillin, and Clarithromycin
- Lanreotide-Adalimumab-adbm Subcutaneous
- Lanreotide-Adalimumab-atto Subcutaneous
- Lanreotide-Adapalene
- Lanreotide-Adapalene and Benzoyl Peroxide
- Lanreotide-Adapalene and Benzoyl Peroxide Gel
- Lanreotide-Adapalene and benzoyl peroxide topical